Results for tag: "Histone Deacetylase"

Histone Deacetylase (HDAC) is an enzyme that plays a role in gene expression and epigenetic regulation. HDACs are involved in the removal of acetyl groups from lysine residues on histone proteins, which can lead to the condensation of chromatin and the repression of gene expression. HDAC inhibitors are used in the treatment of cancer, neurodegenerative diseases, and other diseases. The HDAC market is a rapidly growing market, driven by the increasing prevalence of cancer and other diseases. The market is expected to benefit from the increasing demand for HDAC inhibitors, as well as the development of new drugs and therapies. The HDAC market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Merck, Novartis, Pfizer, AbbVie, and AstraZeneca. Show Less Read more